A network meta-analysis examining 105 randomized controlled trials with over 219,000 participants found no significant association between GLP-1 receptor agonists and increased infection risk, including urinary tract infections
Its not surprising, then, that results from Mercers National Survey of Employer-Sponsored Health Plans 2023 show that fewer than half of large employers (42% of those with 500 or more employees) currently cover GLP-1 medications for treatment of obesity, although another 19% say they are considering it
This wasnt just a GLP-1 agonist
Medication options - Offering both oral and injectable formulations, as well as both semaglutide and tirzepatide, gives users some choice in how they approach treatment
She stopped taking Ozempic in October 2023 and continued to suffer side effects
Together, these findings indicate that extracellular GSH is broken down to fuel the intracellular metabolic and proteogenic processes in cancer cells